Cerecor Inc’s subsidiary ZPC Merger Corp has acquired Zylera Pharmaceuticals from TRx Pharmaceuticals LLC for $27m.

Cerecor is a US-based clinical-stage biopharmaceutical company that develops drugs for the treatment of neurological and psychiatric disorders.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The company aims to expand its footprint in paediatric healthcare through the acquisition.

Body and Mind Inc’s subsidiary DEP Nevada Inc has acquired the entire issued and outstanding membership units of Nevada Medical Group LLC (NMG) from the latter’s members.

The acquisition was made through a share exchange agreement, under which the acquirer company offered shares of its common stock to NMG members.

In addition, the firm cleared NMG’s outstanding loan of $230,000 to TI Nevada.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Clinical Trials Arena Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving clinical trials industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now